Product Categories
| Country: | China |
|---|---|
| Tel: | 400-6206333 |
| Mobile: | 13167063860 |
| E-mail: | market@aladdin-e.com |
| QQ: | 3004013043 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Tregalizumab (anti-CD4) | 1207446-68-1 | Details |
| Cusatuzumab (anti-CD70) | 1864871-20-4 | Details |
| Lorvotuzumab (anti-CD56) | 339306-30-8 | Details |
| Teplizumab (anti-CD3e) | 876387-05-2 | Details |
| Ibalizumab (anti-CD4) | 680188-33-4 | Details |
| Teprotumumab (anti-IGF1R) | 1036734-93-6 | Details |
| Onartuzumab (anti-MET) | 1133766-06-9 | Details |
| Omburtamab (anti-CD276) | 1895083-75-6 | Details |
| Olokizumab (anti-IL-6) | 1007223-17-7 | Details |
| Onvatilimab (anti-VISTA) | 1969313-51-6 | Details |
| Penpulimab (anti-PDCD1) | 2350298-92-7 | Details |
| Patritumab (anti-ERBB3) | 1262787-83-6 | Details |
| Varlilumab (anti-TNFRSF7) | 1393344-72-3 | Details |
| Talquetamab (anti-GPRC5D) | 2226212-40-2 | Details |
| Brentuximab (anti-TNFRSF8) | 2088770-90-3 | Details |
| Farletuzumab (anti-FOLR1) | 896723-44-7 | Details |
| Blosozumab (anti-SOST) | 1132758-87-2 | Details |
| Fletikumab (anti-IL-20) | 1357158-22-5 | Details |
| Sifalimumab (anti-IFNa1) | 1006877-41-3 | Details |
| Rovalpituzumab (anti-DLL3) | 1613313-01-1 | Details |
| Figitumumab (anti-IGF1R) | 943453-46-1 | Details |
| Zilovertamab (anti-ROR1) | 2485779-13-1 | Details |
| Selicrelumab (anti-CD40) | 1622140-49-1 | Details |
| Envafolimab (anti-PD-L1) | 2102192-68-5 | Details |
| Sotigalimab (anti-CD40) | 2305607-45-6 | Details |
| Fezakinumab (anti-IL-22) | 1007106-86-6 | Details |
| Etrolizumab (anti-α4β7) | 1044758-60-2 | Details |
| Simtuzumab (anti-LOXL2) | 1318075-13-6 | Details |
| Oleclumab (anti-CD73) | 1803176-05-7 | Details |
| Sofituzumab (anti-MUC16) | 1615692-28-8 | Details |
| Motavizumab (anti-RSV-F) | 677010-34-3 | Details |
| Aprutumab (anti-FGFR2) | 1634620-63-5 | Details |
| Etokimab (anti-IL-33) | 2022981-44-6 | Details |
| Abituzumab (anti-ITGAV) | 1105038-73-0 | Details |
| Belantamab (anti-TNFRSF17) | 2061894-48-0 | Details |
| Mupadolimab (anti-CD73) | 2451856-97-4 | Details |
| Mepolizumab (anti-IL-5) | 196078-29-2 | Details |
| Canakinumab (Anti-IL-1b) | 914613-48-2 | Details |
| Anifrolumab (anti-IFNAR1) | 1326232-46-5 | Details |
| Nadunolimab (anti-IL-1 RAcP) | 2171061-85-9 | Details |
| Naxitamab (anti-GD2) | 1879925-92-4 | Details |
| Tremelimumab (anti-CTLA-4) | 745013-59-6 | Details |
| Amatuximab (anti-MSLN) | 931402-35-6 | Details |
| Mavrilimumab (anti-CD116) | 1085337-57-0 | Details |
| Vibostolimab (anti-TIGIT) | 2231305-30-7 | Details |
| Relatlimab (anti-LAG-3/CD223) | 1673516-98-7 | Details |
| Aducanumab (anti-APP) | 1384260-65-4 | Details |
| Bemarituzumab (anti-FGFR2) | 1952272-74-0 | Details |
| Sabatolimab (anti-TIM-3) | 2252262-24-9 | Details |
| Otelixizumab (anti-CD3) | 881191-44-2 | Details |
| Magrolimab (anti-CD47) | 2169232-81-7 | Details |
| Panitumumab (anti-EGFR) | 339177-26-3 | Details |
| Muromonab (anti-CD3) | 140608-64-6 | Details |
| Denosumab (anti-TNFSF11) | C6404H9912N1724O2004S50 | 615258-40-7 | Details |
| Eptinezumab (anti-CGRP) | 1644539-04-7 | Details |
| Mirvetuximab (anti-FOLR1) | 1453084-36-0 | Details |
| Sacituzumab (anti-TROP2) | 1796566-95-4 | Details |
| Ofatumumab (anti-CD20) | 679818-59-8 | Details |
| Emicizumab (anti-Factor IX) | 1610943-06-0 | Details |
| Margetuximab (anti-HER2) | 1350624-75-7 | Details |
| Erenumab (anti-CALCRL) | 1582205-90-0 | Details |
| Sintilimab (anti-PD-1) | 2072873-06-2 | Details |
| Zanamivir | C12H20N4O7 | 139110-80-8 | Details |
| Zandelisib | C31H38F2N8O | 1401436-95-0 | Details |
| Zileuton (A-64077) | C11H12N2O2S | 111406-87-2 | Details |
| Omalizumab (anti-IgE) | 242138-07-4 | Details |
| Tiragolumab (anti-TIGIT) | 1918185-84-8 | Details |
| Zoledronic Acid Disodium Salt Tetrahydrate | C5H13N2NaO8P2 | 165800-07-7 | Details |
| Zinc acetylacetonate hydrate | C10H14O4Zn | 108503-47-5 | Details |
| Zalcitabine | C9H13N3O3 | 7481-89-2 | Details |
| Zolantidine dimaleate | C22H27N3OS2C4H4O4 | 104076-39-3 | Details |
| Zibotentan (ZD4054) | C19H16N6O4S | 186497-07-4 | Details |
| Necitumumab (anti-EGFR) | 906805-06-9 | Details |
| Zolmitriptan | C16H21N3O2 | 139264-17-8 | Details |
| Zirconium acetate | C2H4O2Zr | 7585-20-8 | Details |
| Zirconium hydroxide | H4O4Zr | 14475-63-9 | Details |
| Recombinant Human VEGF Protein | NULL | 127464-60-2 | Details |
| Z-LEHD-FMK TFA | C34H44F4N6O12 | 524746-03-0 | Details |
| ZM 306416 | C16H13ClFN3O2 | 690206-97-4 | Details |
| Zearalenone from Giberella zeae | C18H22O5 | 17924-92-4 | Details |
| Zaltoprofen | C17H14O3S | 74711-43-6 | Details |
| Zoledronic Acid | C5H10N2O7P2 | 118072-93-8 | Details |
| Zebularine (NSC 309132) | C9H12N2O5 | 3690-10-6 | Details |
| Pamrevlumab (anti-CTGF) | 946415-13-0 | Details |
| Spartalizumab (anti-PD-1) | 1935694-88-4 | Details |
| Vedolizumab (anti-α4β7-integrin) | 943609-66-3 | Details |
| Emapalumab (anti-IFNγ) | 1709815-23-5 | Details |
| ZM 39923 HCl | C23H26ClNO | 1021868-92-7 | Details |
| Zinc Pyrithione | C10H8N2O2S2Zn | 13463-41-7 | Details |
| Zinc iron oxide | Fe2O4Zn | 12063-19-3 | Details |
| Evolocumab(anti-PCSK9) | 1256937-27-5 | Details |
| Evinacumab (anti-ANGPTL3) | 1446419-85-7 | Details |
| Zinc fluoborate hydrate | BF4H2OZn+ | 27860-83-9 | Details |
| Zafirlukast (ICI-204219) | C31H33N3O6S | 107753-78-6 | Details |
| Zinc selenide | SeZn | 1315-09-9 | Details |
| Brodalumab (anti-IL17RA) | 1174395-19-7 | Details |
| Risankizumab (anti-IL-23) | 1612838-76-2 | Details |
| Z-FA-FMK | C21H23FN2O4 | 197855-65-5 | Details |
| Siltuximab (anti-IL-6) | 541502-14-1 | Details |
| Isatuximab (anti-CD38) | 1461640-62-9 | Details |
| Product Total： Product Page： | ||||
| 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 | ||||